Our finding that the macrophage‐associated factor significantly predicts LM severity aligns with a prior study that identified MIP‐1β as a significant predictor of difficult‐to‐treat CRS status after 1 year of follow‐up [47]. The gene discussed is CCL4; the disease is lymphangioma.